ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026
Clinical characteristics and risk factors of mortality in patients with candidemia: a four-year retrospective study.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAlthough candidemia has been reported globally, little is known about the differences in candidemia episodes between ICU and regular wards or the correlation between serum biomarkers and mortality from candidemia in medium and small cities. PATIENTS AND
methodsWe conducted a retrospective study of the risk factors and clinical outcomes of hospitalized patients with candidemia from 2021 to 2024 in southwest China. A multivariate logistic regression model was performed to investigate several potential risk factors for mortality.
resultsWe collected 152 non-duplicate candidemia isolates during the study period. Candida albicans was the leading species causing candidemia (33.6%), and 96.7% of these isolates were susceptible to amphotericin B. Compared with regular patients, patients admitted to ICU were more frequently subjected to severe clinical presentations, extensive invasive procedures, and heavy exposure to antibiotics. In addition, the mortality in ICU was significantly higher than that in regular wards. Multivariable analysis revealed that 30-day readmission, mechanical ventilation, and ICU admission were independent factors associated with 30-day mortality. Moreover, we observed that high levels of PCT, BDG, and IL-6, as well as low PLT counts were also associated with mortality from candidemia.
conclusionsA better understanding of the specific risk factors across ICU wards could facilitate the identification of high-risk candidates for early antifungal therapy, thereby improving the outcomes for critically ill patients with candidemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.